Company registration number 10299351 (England and Wales)
ONLY ONCOLOGY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
PAGES FOR FILING WITH REGISTRAR
ONLY ONCOLOGY LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
ONLY ONCOLOGY LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2023
31 December 2023
- 1 -
2023
2022
Notes
£
£
£
£
Current assets
Debtors
3
100
100
Net current assets
100
100
Capital and reserves
-
-
Called up share capital
100
100

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 27 June 2024
G E Peterson
Director
Company Registration No. 10299351
ONLY ONCOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
- 2 -
1
Accounting policies
Company information

Only Oncology Limited is a private company limited by shares incorporated in England and Wales. The registered office is Mere House, Brook Street, Knutsford, Cheshire, WA16 8GP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

2
Employees

The company has no employees other than the director.

3
Debtors
2023
2022
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
100
100
4
Related party transactions

The company has taken advantage of the available exemption conferred by Section 1AC.35 of FRS 102 not to disclose transactions with wholly owned members of the group.

5
Parent company

The company's immediate parent undertaking is Prime Global Medical Communications Ltd, a company incorporated in England and Wales and registered at Mere House, Brook Street, Knutsford, Cheshire, WA16 8GP. The results of this company are included in the consolidated accounts of Prime Global Medical Communications Ltd.

2023-12-312023-01-01trueCCH SoftwareCCH Accounts Production 2024.100No description of principal activityG E PetersonG E Petersonfalsefalse102993512023-01-012023-12-31102993512023-12-31102993512022-12-3110299351core:ShareCapital2023-12-3110299351core:ShareCapital2022-12-3110299351bus:CompanySecretaryDirector12023-01-012023-12-3110299351core:CurrentFinancialInstruments2022-12-3110299351bus:EntityNoLongerTradingButTradedInPast2023-01-012023-12-3110299351bus:PrivateLimitedCompanyLtd2023-01-012023-12-3110299351bus:SmallCompaniesRegimeForAccounts2023-01-012023-12-3110299351bus:FRS1022023-01-012023-12-3110299351bus:AuditExempt-NoAccountantsReport2023-01-012023-12-3110299351bus:Director12023-01-012023-12-3110299351bus:CompanySecretary12023-01-012023-12-3110299351bus:FullAccounts2023-01-012023-12-31xbrli:purexbrli:sharesiso4217:GBP